Comparative dosimetric assessment of combined treatment modalities in cervical cancer radiotherapy for optimal organ protection

被引:0
|
作者
Gazsi, Iozsef [1 ,2 ]
Marcu, Loredana G. [3 ,4 ]
机构
[1] West Univ Timisoara, Fac Phys, Timisoara 300223, Romania
[2] Emergency Cty Hosp, Oradea 410167, Romania
[3] Univ South Australia, UniSA Allied Hlth & Human Performance, Adelaide, SA 5001, Australia
[4] Univ Oradea, Fac Informat & Sci, Oradea 410087, Romania
关键词
3D-conformal radiotherapy; Intensity modulated radiotherapy; Volumetric modulated arc therapy; Brachytherapy; Organs at risk; Combined radiotherapy; Dosimetry; GUIDED ADAPTIVE BRACHYTHERAPY; INTRACAVITARY BRACHYTHERAPY; CLINICAL-OUTCOMES; VOLUME; CHEMORADIATION; PARAMETERS; CARCINOMA; APPLICATORS; EVOLUTION; HEAD;
D O I
10.1007/s00411-025-01113-7
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
External radiotherapy combined with internal radiotherapy in cervical cancer can provide a boost to the target volume to increase tumour control. At the same time internal radiotherapy protects neighboring organs. The aim of the present study was to dosimetrically compare three external beam radiotherapy techniques each combined with internal radiotherapy to evaluate the combination that offers the best organ protection. Treatment plans of 20 cervical cancer patients were created for external (including three-dimensional conformal radiotherapy (3D-CRT), intensity modulated radiotherapy (IMRT) and volumetric modulated arc therapy (VMAT)) as well as brachytherapy. The prescribed dose was 50 Gy in 25 fractions for external and 21 Gy in three fractions for internal radiotherapy. The following organs at risk (OARs) were evaluated: bladder, rectum, sigmoid and bowel bag. The study analyzed the results of different treatment combinations in terms of dosimetric values for various parameters. The D90 for the clinical target volume was around 120 Gy, with the highest value seen in 3D-CRT + BT (brachytherapy) combination at 120.59 Gy. For the bladder, the D2cc remained below the recommended threshold of 90 Gy, with the lowest value obtained for the BT + IMRT combination at 79.2 Gy. For the rectum, both D2cc and D1cc remained below the recommended threshold of 75 Gy for both parameters. All techniques fell below the recommended dose of 75 Gy for the sigmoid. For the intestine, there were statistically significant differences between BT + IMRT and BT + 3D-CRT. The VMAT technique showed superiority over IMRT in tumour volume coverage and several organ-at-risk parameters. Generally, intensity-modulated techniques showed dosimetric advantage over the traditional 3D technique in cervical cancer. In addition to providing better compliance and homogeneity, they provided superior protection for organs at risk, especially for bowel bag. It is concluded that the BT + IMRT technique provided the best protection for organs at risk based on the lowest OAR dosimetric values, especially for the intestine.
引用
收藏
页码:291 / 302
页数:12
相关论文
共 50 条
  • [1] Dosimetric Evaluation of Cervical Oesophagus as an Organ at Risk in Breast Cancer Radiotherapy
    Thimmaiah, Naveen
    Bhaskar, Nithin
    Saini, Ayushee
    Shivananjappa, Rashmi
    Pasha, Tanvir
    Palanivel, Sathiyaraj
    Radhakrishna, Nikhila
    EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY, 2024, 8 (03): : 336 - 340
  • [2] Dosimetric comparison of different treatment modalities for stereotactic radiotherapy
    Hsu, Shih-Ming
    Lai, Yuan-Chun
    Jeng, Chien-Chung
    Tseng, Chia-Ying
    RADIATION ONCOLOGY, 2017, 12
  • [3] Dosimetric comparison of different treatment modalities for stereotactic radiotherapy
    Shih-Ming Hsu
    Yuan-Chun Lai
    Chien-Chung Jeng
    Chia-Ying Tseng
    Radiation Oncology, 12
  • [4] COMPARATIVE CLINICO-DOSIMETRIC ANALYSIS OF RADIOTHERAPY VARIANTS IN PATIENTS WITH CERVICAL-CANCER
    BEIBUTOV, SM
    KAZHLAEVA, UI
    SAMSONOVA, ZA
    VOPROSY ONKOLOGII, 1977, 23 (02) : 107 - 111
  • [5] A Dosimetric Assessment of Sexual Organ Sparing Proton Radiotherapy in Female Pelvic Cancer Patients
    Marshall, D. C.
    Shim, A.
    Chen, C. C.
    Lin, H.
    Yu, F.
    Argiriadi, P.
    Choi, I. J.
    Chhabra, A. M.
    Simone, C. B., II
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E695 - E695
  • [6] Organ contouring in cervical cancer radiotherapy
    Dimopoulos, J
    Nguyen, F
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S58 - S58
  • [7] Comparative Evaluation of Dosimetric Quality and Treatment Efficiency for Halcyon, TrueBeam, and TomoTherapy in Cervical-Thoracic Esophageal Cancer Radiotherapy
    Chen, Shilin
    Wang, Jiazhou
    Hu, Weigang
    Xu, Yao
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2024, 23
  • [8] RADIOTHERAPY COMBINED WITH SURGERY AS TREATMENT FOR ADVANCED CERVICAL-CANCER
    PERCHES, RD
    LOBATON, AT
    GARCIA, MC
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1983, 9 (12): : 1785 - 1788
  • [9] Primary combined radiotherapy in cervical cancer
    Barke, A
    Henne, K
    Röhner, F
    Stange, S
    STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 : 32 - 32
  • [10] COMBINED TREATMENT MODALITIES IN ESOPHAGEAL CANCER
    DESAI, PB
    VYAS, JJ
    SHARMA, S
    DESHPANDE, RK
    BADWE, RA
    ADVANI, SH
    SAIKIA, T
    DINSHAW, KA
    SWAROOP, VS
    SEMINARS IN SURGICAL ONCOLOGY, 1989, 5 (05): : 365 - 369